Key H. Kim

402 total citations
26 papers, 319 citations indexed

About

Key H. Kim is a scholar working on Organic Chemistry, Infectious Diseases and Oncology. According to data from OpenAlex, Key H. Kim has authored 26 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 9 papers in Infectious Diseases and 9 papers in Oncology. Recurrent topics in Key H. Kim's work include HIV/AIDS drug development and treatment (9 papers), Metal complexes synthesis and properties (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). Key H. Kim is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Metal complexes synthesis and properties (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). Key H. Kim collaborates with scholars based in South Korea, Japan and Australia. Key H. Kim's co-authors include Dae-Kee Kim, Jongsik Gam, Weon‐Seon Hong, Hun-Taek Kim, Namkyu Lee, Taek‐Soo Kim, Jae‐Gahb Park, Dae‐Kee Kim, Young‐Woo Kim and Joo Ho Tai and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

In The Last Decade

Key H. Kim

26 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Key H. Kim South Korea 9 149 121 98 59 43 26 319
Michael G. Darcy United States 12 222 1.5× 62 0.5× 135 1.4× 60 1.0× 56 1.3× 13 524
Hongwu Gao United States 12 212 1.4× 77 0.6× 226 2.3× 81 1.4× 63 1.5× 28 472
Katsuji Aikawa Japan 11 257 1.7× 91 0.8× 159 1.6× 29 0.5× 15 0.3× 13 488
Mary Ann M. Fuhry United States 8 260 1.7× 60 0.5× 227 2.3× 57 1.0× 16 0.4× 10 476
Charlotte A. Bartlett United States 6 117 0.8× 92 0.8× 246 2.5× 63 1.1× 23 0.5× 8 396
Robert Gomez United States 13 198 1.3× 59 0.5× 240 2.4× 65 1.1× 25 0.6× 21 431
Clinton M. Yeung United States 11 210 1.4× 86 0.7× 134 1.4× 53 0.9× 57 1.3× 19 407
Robert C. Hider United Kingdom 10 149 1.0× 83 0.7× 67 0.7× 20 0.3× 20 0.5× 18 449
Toomas Mitt United States 12 264 1.8× 51 0.4× 162 1.7× 60 1.0× 34 0.8× 14 396
Timothy A. Stammers Canada 13 220 1.5× 61 0.5× 117 1.2× 82 1.4× 81 1.9× 21 462

Countries citing papers authored by Key H. Kim

Since Specialization
Citations

This map shows the geographic impact of Key H. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Key H. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Key H. Kim more than expected).

Fields of papers citing papers by Key H. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Key H. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Key H. Kim. The network helps show where Key H. Kim may publish in the future.

Co-authorship network of co-authors of Key H. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Key H. Kim. A scholar is included among the top collaborators of Key H. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Key H. Kim. Key H. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Young Bok, Jina Jung, Kiwon Jung, et al.. (2001). Effect of SKI 306X, a New Herbal Anti-Arthritic Agent, in Patients with Osteoarthritis of the Knee: A Double-Blind Placebo Controlled Study. The American Journal of Chinese Medicine. 29(03n04). 485–491. 50 indexed citations
2.
Kim, Dae-Kee, et al.. (1999). Synthesis and evaluation of amino acid esters of 6-deoxypenciclovir as potential prodrugs of penciclovir. Bioorganic & Medicinal Chemistry. 7(2). 419–424. 12 indexed citations
3.
4.
Zang, Dae Young, Kyoo Hyung Lee, Jung Shin Lee, et al.. (1999). Phase II Trial of a Novel Platinum Analog, SKI 2053R, in Patients With Previously Untreated Extensive-Stage Small-Cell Lung Cancer. American Journal of Clinical Oncology. 22(5). 495–495. 5 indexed citations
5.
Kim, Dae‐Kee, et al.. (1999). Synthesis of carbon‐14 labelled 2‐amino‐9‐(3‐hydroxymethyl‐4‐isopropoxycarbonyloxybut‐1‐yl)purine (SK1875), a potential prodrug of penciclovir. Journal of Labelled Compounds and Radiopharmaceuticals. 42(6). 597–604. 1 indexed citations
6.
Kim, Dae-Kee, et al.. (1999). Synthesis and Evaluation of 2-Amino-9-(1,3-dihydroxy-2-propoxymethyl)- 6-fluoropurine Mono- and Diesters as Potential Prodrugs of Ganciclovir. Journal of Medicinal Chemistry. 42(2). 324–328. 5 indexed citations
7.
Kim, Hun-Taek, Taek‐Soo Kim, In‐Ho Jung, et al.. (1997). Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis - malonato[(4 R , 5 R )-4,5-bis(aminomethyl)- 2-isopropyl-1,3-dioxolane]platinum(II). Cancer Chemotherapy and Pharmacology. 41(2). 109–116. 6 indexed citations
8.
Kim, Dae-Kee, et al.. (1997). Synthesis and Anti-HIV-1 Activity of a Series of 1-Alkoxy-5-alkyl-6-(arylthio)uracils. Journal of Medicinal Chemistry. 40(15). 2363–2373. 27 indexed citations
9.
Kim, Key H., et al.. (1997). Synthesis of 6‐substituted 1‐alkoxy‐5‐alkyluracils. Journal of Heterocyclic Chemistry. 34(1). 311–314. 4 indexed citations
10.
Lee, Namkyu, et al.. (1997). A new route to the improved synthesis of 1‐(alkoxymethyl)‐5‐alkyl‐6‐(arylselenenyl)uracils. Journal of Heterocyclic Chemistry. 34(2). 659–663. 5 indexed citations
11.
Kim, Dae‐Kee, et al.. (1996). Synthesis and anti‐HIV‐1 activity of 1,5‐dialkyl‐6‐(arylselenenyl)uracils and ‐2‐thiouracils. Journal of Heterocyclic Chemistry. 33(3). 885–894. 5 indexed citations
12.
13.
Gam, Jongsik, et al.. (1996). Synthesis and antitumor activity of (2R,3R)-2,3-dihydroxy- and -2,3-dialkoxy-1,4-diaminobutane platinum(II) complexes. Bioorganic & Medicinal Chemistry Letters. 6(6). 647–652. 4 indexed citations
14.
Gam, Jongsik, et al.. (1996). Synthesis and anti‐HIV‐1 activity of a series of 1‐(alkoxymethyl)‐5‐alkyl‐6‐(arylselenenyl)uracils and ‐2‐thiouracils. Journal of Heterocyclic Chemistry. 33(4). 1275–1283. 12 indexed citations
15.
Lee, Namkyu, et al.. (1996). Enantioselective synthesis of (R)- and (S)-2-alkyl-1,4-butanediolsvia enantiomerically pure 3-alkyl-5-(menthyloxy)butyrolactones. Tetrahedron Letters. 37(14). 2429–2432. 10 indexed citations
16.
Kim, Dae-Kee, et al.. (1995). Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy]guanine against cytomegalovirus and herpes simplex virus. Antiviral Research. 28(3). 243–251. 2 indexed citations
17.
Kim, Dae-Kee, et al.. (1995). Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethy1)-2-isopropyl-1,3-dioxolanelplatinum(II), a new platinum analogue, as an anticancer agent. Cancer Chemotherapy and Pharmacology. 35(5). 441–445. 27 indexed citations
18.
Kim, Dae‐Kee, et al.. (1995). Synthesis of 1‐alkoxy‐5‐alkyluracils. Journal of Heterocyclic Chemistry. 32(5). 1625–1629. 3 indexed citations
19.
Kim, Dae-Kee, Jongsik Gam, Hun-Taek Kim, et al.. (1994). Synthesis and Antitumor Activity of a Series of [2-Substituted-4,5-bis(aminomethyl)-1,3-Dioxolane]platinum(II) Complexes. Journal of Medicinal Chemistry. 37(10). 1471–1485. 69 indexed citations
20.
Kim, Dae-Kee, Young Woo Kim, & Key H. Kim. (1994). Synthesis and anti-HCMV activity of 9-[[(ethoxyhydroxyphosphinyl)methoxy]methoxy]guanine, an isostere of PMEG monoethyl ester. Bioorganic & Medicinal Chemistry Letters. 4(18). 2241–2244. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael G. Darcy Breakdown of academic impact, for papers by Hongwu Gao Breakdown of academic impact, for papers by Katsuji Aikawa Breakdown of academic impact, for papers by Mary Ann M. Fuhry Breakdown of academic impact, for papers by Charlotte A. Bartlett Breakdown of academic impact, for papers by Robert Gomez Breakdown of academic impact, for papers by Clinton M. Yeung Breakdown of academic impact, for papers by Robert C. Hider Breakdown of academic impact, for papers by Toomas Mitt Breakdown of academic impact, for papers by Timothy A. Stammers
Rankless by CCL
2026